CullmanTimes.com - Cullman, Alabama

Health

June 5, 2014

Sanofi targets fake Viagra market with non-prescription Cialis

LONDON — Sanofi sees an attractive opportunity in the rampant market for counterfeit Viagra: luring men away from dodgy online pharmacies with an over-the-counter version of a competing erection drug.

The French drugmaker plans safety and efficacy studies to support an application to produce a non-prescription version of Eli Lilly & Co.'s Cialis. One selling point is to provide a legal and effective alternative to fake copies of Pfizer's Viagra and other drugs, said Vincent Warnery, senior vice president of global consumer health care at Sanofi.

"The vast majority of men don't consult their doctor on erectile dysfunction," Warnery said at a consumer health-care conference in London Wednesday. "Men search online for drugs they can access directly, and in doing so they expose themselves to the huge risks of counterfeit drugs."

Fake versions of Viagra, one of the most copied medicines in the world, are abundant on the Internet, and that puts consumers at risk. Of more than 10,000 online outlets surveyed last year by the National Association of Boards of Pharmacy, 97 percent were out of compliance with U.S. pharmacy laws and standards.

Sanofi, based in Paris, said last week it agreed to work with Lilly on over-the-counter Cialis, a $2 billion a year drug that loses patent protection in 2017. Lilly turned to Sanofi because the Indianapolis-based company doesn't have as much experience with non-prescription medicines, Warnery said.

"Looking at what Lilly has shown us, we believe we are in a good place," the executive said.

Even so, the approach to regulators follows a similar attempt by Pfizer that the New York-based company abandoned. Pfizer sought approval for an OTC version of Viagra in Europe and withdrew its application in 2008 given concerns raised by the European Union's drug regulator.

Guido Rasi, executive director of the European Medicines Agency, said the regulator would need to "seriously analyze" why Pfizer's over-the-counter application wasn't successful.

Pfizer's little blue pills caused a sexual revolution for millions of men when they were introduced 16 years ago, replacing treatments that included penile injections and surgery. More than 18 million Americans older than age 20 suffer from erection difficulties, according to Johns Hopkins University's Bloomberg School of Public Health.

Interpol said last month it shut down more than 10,000 websites offering illicit pharmaceuticals. Among the 9.4 million medicines seized were erectile dysfunction pills, according to the police agency.

Given Sanofi and Eli Lilly's plan, Pfizer may revisit making non-prescription Viagra, said Andy Tisman, consumer health-care consultant at IMS Health in London.

Pfizer reached an agreement in December with Teva Pharmaceutical Industries Ltd. that permits the Israeli drugmaker to market a generic version of Viagra in the U.S. starting in 2017.

"We are evaluating a number of prescription drugs for potential switch to non-prescription status, and are focusing on categories that will have the greatest positive impact to people and the health-care system overall," Sally Beatty, a Pfizer spokeswoman, said in an e-mail.

 

1
Text Only
Health
  • COMMENTARY: An alternative diagnosis to ADHD: Schoolchildren need more time to move

    The Centers for Disease Control and Prevention tells us that in recent years, there has been a jump in the percentage of young people diagnosed with attention deficit and hyperactivity disorder, commonly known as ADHD: 7.8 percent in 2003 to 9.5 percent in 2007 to 11 percent in 2011.

    July 18, 2014

  • Guideline: Most healthy women can skip pelvic exam

    No more dreaded pelvic exam? New guidelines say most healthy women can skip the yearly ritual.

    July 1, 2014

  • Sanofi targets fake Viagra market with non-prescription Cialis

    Sanofi sees an attractive opportunity in the rampant market for counterfeit Viagra: luring men away from dodgy online pharmacies with an over-the-counter version of a competing erection drug.

    June 5, 2014

  • Hospital charges to treat chest pain jump 10 percent in a year

    The charge to treat Medicare patients with chest pain at U.S. hospitals rose 10 percent to $18,568 in just a year, the biggest rise seen among the most common inpatient procedures, according to federal data.

    June 2, 2014

  • Study: Both men and women feel less stress at work than at home

    In a newly released study in the Journal of Science and Medicine, researchers carefully examined the levels of the stress hormone, cortisol, of a variety of workers throughout the day. The data clearly showed that both men and women are significantly less stressed out at work than they are at home.
     And the women they studied said they were happier at work. While the men said they felt happier at home.

    May 26, 2014

  • Jobless contend with weight gain as they search for work

    A subject long ignored by policymakers, and one that unemployment counselors are too sheepish to raise with job seekers, the link between bulging waistlines and joblessness is now of intense interest to researchers studying the long-term effects of the country's economic malaise.

    May 12, 2014

  • COMMENTARY: Helmets won't protect your kids from concussions

    When I was a kid, helmets were for motorcyclists. Now I see children wearing helmets when they're scooting down sidewalks, skating, skiing, sledding and playing soccer. Last week one of my friends saw a helmeted kid power-walking in Prospect Park. You can even buy $40 baby helmets on Amazon, because, according to the product description, "babies will always fall taking their first steps."

    May 2, 2014

  • 400px-Cannabis_Plant.jpg How bad is marijuana for your health?

    The Journal of Neuroscience recently published a study linking recreational marijuana use to subtle changes in brain structure. The researchers, led by Jodi Gilman of Massachusetts General Hospital, identified increased gray matter density in the left nucleus accumbens and some bordering areas.

    May 1, 2014 1 Photo

  • American sunscreens need an upgrade

    The last time a new sunscreen ingredient came on the U.S. market, the Y2K bug was threatening to destroy our way of life. Intel had just introduced the Pentium III processor, featuring an amazing 500 MHz of computing power.

    April 24, 2014

  • Cuba is running out of condoms

    The newest item on Cuba's list of dwindling commodities is condoms, which are now reportedly in short supply. In response, the Cuban government has approved the sale of expired condoms.

    April 23, 2014